← Leaderboards
Asuncion Mejias
Emory University
$2,044,603
Attributed
$3,101,254
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $992.5K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,101,254 · 7
By mechanism
U19$1,095,813 · 1
R01$794,661 · 1
P01$735,201 · 1
R21$459,079 · 1
R13$16,500 · 3
Top collaborators
- Susan Creary3 shared
- Darryl Brice Hood3 shared
- Benjamin T Kopp3 shared
- Raymond F. Schinazi3 shared
- Octavio Ramilo2 shared
- Matthew Z Anderson1 shared
- Gregory C. Gibson1 shared
- Vivien Andrea Sheehan1 shared
Most similar at Emory University
Same institution · by research overlap
- Raymond F. Schinazi$18,319,973
- Susan Creary$2,068,115
- Darryl Brice Hood$3,153,688
- Benjamin T Kopp$3,476,580
- Peter A Lane$654,618
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneBloodSamplingInfantViralChildImmunologyInfectionRespiratoryCovid-19ProgramsClinical ResearchLongitudinal CohortInfluenzavirusVariantShapesVaccine DevelopmentImmune Response2019-NcovAcuteFutureVaccinesLifeGene Expression Profile
Grant awards (15)
SMILE (Sickle Cell Disease Microbiologic and Immunologic Links to Health)$794,661
R01 · FY2025 · HL
Clinical Core$192,789
U19 · FY2025 · AI · contact PI
Respi-DART: Frontiers in drug development against respiratory viruses and emerging viruses$5,000
R13 · FY2025 · AI
Clinical Core$290,923
U19 · FY2024 · AI · contact PI
SMILE: Sickle Cell Disease Microbiologic and Immunologic Links to Health Equity$236,634
R21 · FY2024 · AI
Clinical Core$318,447
U19 · FY2023 · AI · contact PI
SMILE: Sickle Cell Disease Microbiologic and Immunologic Links to Health Equity$222,445
R21 · FY2023 · AI
RespiDART 2022: Frontiers in Drug Development against Respiratory Viruses$6,500
R13 · FY2023 · AI
Clinical Core$293,654
U19 · FY2022 · AI · contact PI
RespiDART & Emerging Viruses: Frontiers in Drug Development against Respiratory Viruses$5,000
R13 · FY2021 · AI
Immune Profiles as Markers of Safe and Protective RSV Vaccines$175,833
P01 · FY2019 · AI · contact PI
Immune Profiles as Markers of Safe and Protective RSV Vaccines$177,772
P01 · FY2018 · AI · contact PI
Immune Profiles as Markers of Safe and Protective RSV Vaccines$151,322
P01 · FY2017 · AI · contact PI
Immune Profiles as Markers of Safe and Protective RSV Vaccines$155,195
P01 · FY2016 · AI · contact PI
Immune Profiles as Markers of Safe and Protective RSV Vaccines$75,079
P01 · FY2015 · AI · contact PI